CREDIT SUISSE NEW ISSUE: 6 American Call Warrants on Roche Holding Donnerstag, 18. November 2021 - 10:05
Dear Investor
Please find hereafter the details for these new issues:
Ticker | Valor | ISIN | Underlying | Spot | Strike | Ratio | Maturity | Type | Issue price | Impl. Vola | PDF File |
UROGCS | 11 485 0102 | CH 114 850 102 1 | Roche Holding AG | CHF 370.00 | CHF 380.00 | 50:1 | 17.06.2022 | Call | CHF 0.30 | 19.35% | |
VROGCS | 11 485 0103 | CH 114 850 103 9 | Roche Holding AG | CHF 370.00 | CHF 390.00 | 50:1 | 17.06.2022 | Call | CHF 0.23 | 19.43% | |
WROGCS | 11 485 0104 | CH 114 850 104 7 | Roche Holding AG | CHF 370.00 | CHF 400.00 | 50:1 | 17.06.2022 | Call | CHF 0.18 | 19.63% | |
XROGCS | 11 485 0105 | CH 114 850 105 4 | Roche Holding AG | CHF 370.00 | CHF 380.00 | 50:1 | 16.12.2022 | Call | CHF 0.46 | 20.36% | |
YROGCS | 11 485 0106 | CH 114 850 106 2 | Roche Holding AG | CHF 370.00 | CHF 400.00 | 50:1 | 16.12.2022 | Call | CHF 0.33 | 20.26% | |
ZROGCS | 11 485 0107 | CH 114 850 107 0 | Roche Holding AG | CHF 370.00 | CHF 420.00 | 50:1 | 16.12.2022 | Call | CHF 0.24 | 20.40% |
Please visit our website http://www.credit-suisse.com/derivatives to see the complete list of our products.
The warrants will be placed directly in the secondary market. Please call 044/335 76 00.
Kind regards
CREDIT SUISSE AG
Investment Banking
Equity Derivatives & Structured Products
Uetlibergstrasse 231
8070 Zürich, Switzerland
Tel: +41 44 - 335 76 00
Fax: +41 44 - 333 78 08
www.credit-suisse.com
This message may contain confidential, proprietary or legally privileged information and is intended only for the use of the addressee named above. No confidentiality or privilege is waived or lost by any mistransmission. If you are not the intended recipient of this message you are hereby notified that you must not use, disseminate, copy it in any form or take any action in reliance on it. If you have received this message in error please delete it and any copies of it and notify the sender immediately. Credit Suisse Group and its subsidiaries reserve the right to intercept and monitor any e-mail communication through its networks if legally allowed.